In treatment-naïve patients, the sensitivity for detecting lymph node metastases is 33–100% for PSMA PET-CT [7–10], 19–78% for choline PET/CT, 33–57% for DWI MRI [11–13], and 5–94% for CT [14]. This evidence concerns the gene FOLH1 and metastatic malignant neoplasm in the lymph nodes.